Corcept Therapeutics Incorporated (CORT)
NASDAQ: CORT · IEX Real-Time Price · USD
28.09
+0.55 (2.00%)
At close: May 17, 2024, 4:00 PM
28.28
+0.19 (0.68%)
After-hours: May 17, 2024, 5:18 PM EDT

Corcept Therapeutics Revenue

Corcept Therapeutics had revenue of $523.53M in the twelve months ending March 31, 2024, with 26.51% growth year-over-year. Revenue in the quarter ending March 31, 2024 was $146.81M with 38.95% year-over-year growth. In the year 2023, Corcept Therapeutics had annual revenue of $482.38M with 20.04% growth.

Revenue (ttm)
$523.53M
Revenue Growth
+26.51%
P/S Ratio
5.59
Revenue / Employee
$1,487,298
Employees
352
Market Cap
2.92B USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2023482.38M80.52M20.04%
Dec 31, 2022401.86M35.88M9.80%
Dec 31, 2021365.98M12.10M3.42%
Dec 31, 2020353.87M47.39M15.46%
Dec 31, 2019306.49M55.24M21.99%
Dec 31, 2018251.25M92.05M57.82%
Dec 31, 2017159.20M77.88M95.77%
Dec 31, 201681.32M31.04M61.72%
Dec 31, 201550.29M23.74M89.39%
Dec 31, 201426.55M16.19M156.36%
Dec 31, 201310.36M7.05M213.18%
Dec 31, 20123.31M--
Dec 31, 20110--
Dec 31, 20100--
Dec 31, 200929.00K-180.00K-86.12%
Dec 31, 2008209.00K-273.00K-56.64%
Dec 31, 2007482.00K188.00K63.95%
Dec 31, 2006294.00K--
Dec 31, 20050--
Dec 31, 20040--
Dec 31, 20030--
Dec 31, 20020--
Dec 31, 20010--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
QuidelOrtho 2.86B
Neogen 929.24M
iRhythm Technologies 513.17M
Amicus Therapeutics 423.49M
Denali Therapeutics 295.39M
MorphoSys AG 264.75M
Olink Holding AB (publ) 170.89M
Arcellx 131.66M
Revenue Rankings